Company Amexdrug Corporation Other OTC
Equities
AXRX
US0311392072
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2023 | Weight | Delta |
---|---|---|---|
Pharmaceuticals
100.0
%
| 4 | 100.0 % | - |
Sales per region
USD in Million | 2023 | Weight | Delta |
---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jack Amin
CEO | Chief Executive Officer | 64 | 01/00/01 |
Robert Wilkinson
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jack Amin
CEO | Chief Executive Officer | 64 | 01/00/01 |
Behrooz Meimand
BRD | Director/Board Member | 74 | 01/01/01 |
Rodney Barron
BRD | Director/Board Member | 70 | 01/01/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 169,409,620 | 14,225,580 ( 8.397 %) | 0 | 8.397 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+17.42% | 71.72B | |
-3.33% | 24.29B | |
+7.71% | 8.31B | |
-19.61% | 8.22B | |
+1.47% | 8.16B | |
+5.56% | 4.76B | |
+15.41% | 4.31B | |
-0.87% | 4.1B | |
+23.20% | 3.78B |